Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma.

Giusti, Massimo

Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma. [electronic resource] - Hormones (Athens, Greece) - 304-13 p. digital

Publication Type: Journal Article

1109-3099

10.14310/horm.2002.1111026 doi


Adult
Aged
Aging
Calcium--urine
Creatinine--urine
Female
Humans
Hydroxyproline--urine
Iodine Radioisotopes--therapeutic use
Male
Middle Aged
Osteoporosis--physiopathology
Osteoprotegerin--blood
Postmenopause
Premenopause
RANK Ligand--blood
Recombinant Proteins--administration & dosage
Thyroid Neoplasms--blood
Thyroidectomy
Thyrotropin--administration & dosage
Thyroxine--administration & dosage